Announcements Trials

Browse Landscape

Phase

Phase 2 4 Phase NA 1 Phase 3 1 Phase 1/2 1

Status

Completed 4 Unknown 1 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 72 Breast Neoplasms 63 Neoplasms 59 Leukemia, Myeloid, Acute 58 Multiple Myeloma 52 Colorectal Neoplasms 48 Lymphoma 46 Stomach Neoplasms 43 Recurrence 43 Carcinoma, Hepatocellular 43 Pancreatic Neoplasms 40 Neoplasm Metastasis 39 Melanoma 34 Prostatic Neoplasms 33 Leukemia 30 Lymphoma, Non-Hodgkin 27 Lymphoma, B-Cell 27 Lung Neoplasms 27 Precursor Cell Lymphoblastic Leukemia-Lymphoma 24 Glioblastoma 24 Ovarian Neoplasms 23 Lymphoma, Large B-Cell, Diffuse 21 Esophageal Neoplasms 21 Carcinoma, Renal Cell 20 Myelodysplastic Syndromes 19 Leukemia, Lymphocytic, Chronic, B-Cell 19 Hematologic Neoplasms 19 Colonic Neoplasms 19 Head and Neck Neoplasms 18 Lymphoma, Mantle-Cell 17

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Unknown × Hemangiosarcoma × Clear all

NCT02732678 2016-04-11

PROPAN

Assistance Publique Hopitaux De Marseille

Phase 1/2 Unknown

Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡